Recent trends of treatment and medication peptic ulcerative disorder

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 970-980

  Bhowmik, Debjit ^a   Chiranjib, ^a   Tripathi, K K ^a   Pankaj, ^a   Kumar, K P Sampath ^b  

^a Rajeev Gandhi College of Pharmacy   (India)

^b Department of Microbiology   (India)

Author keywords

Peptic ulcerative disorder

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

ACUPUNCTURE; ANAMNESIS; ARTICLE; BLEEDING; CHIROPRACTIC; DIET SUPPLEMENTATION; DISEASE SEVERITY; DUODENUM ULCER; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERB; HOME CARE; HOMEOPATHY; HUMAN; IDIOPATHIC DISEASE; INFECTION; LIFESTYLE; PEPTIC ULCER; RISK ASSESSMENT; SCAR; STOMACH ULCER; SYMPTOM; TREATMENT DURATION;

EID: 77953389426     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea -- a review. J Am Coll Nutr. 2006;25(2):79-99.
2. Debreceni L, Denes L. Acupuncture treatment for duodenal ulcer. Acupunct Electrother Res. 1988;13(2-3):105-108.
3. Diehl DL. Acupuncture for gastrointestinal and hepatobiliary disorders. J Altern Complement Med. 1999;5(1):27-45.
4. El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-esophageal reflux disease: a cross sectional study in volunteers. Gut. 2005;54(1):11-7.
5. Fox M, Barr C, Nolan S, et al. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol. 2007;5(4):439-44.
6. Fox M, Barr C, Nolan S, Lomer M, Anggiansah A, Wong T. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol. 2007;5(4):439-44.
7. Gorbach SL. Probiotics in the third millennium. Dig Liver Dis. 2002;34(Suppl 2):S2-S7.
8. GrahamDY, Rakel RE, Fendrick AM, et al. Recognizing peptic ulcer disease: keys to clinical and laboratory diagnosis. Postgrad Med. 1999;105(3):113-133.
9. Han KS. The effect of an integrated stress management program on the psychologic and physiologic stress reactions of peptic ulcer in Korea. J Holist Nurs. 2002;20(1):61-80.
10. Jarosz M. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1999;7(60:449-454.
11. Kang JY, Yeoh KG, Chia HP, Lee HP, Chia YW, Guan R, Yap I. Chili -- protective factor against peptic ulcer, Dig Dis Sci. 1995; 40(3):576-579.
12. Khayyal MT , el-Ghazaly MA, Kenawy SA, et al. Antiulcerogenic effect of some gastro intestinally acting plant extracts and their combination. Arzneimittelforschung 2001; 51(7):545-553.
13. Klausz G, Tiszai A, Lenart Z, et al., Helicobacter pylori-induced immunological responses in patients with duodenal ulcer and in patients with cardiomyopathies. Acta Microbiol Immunol Hung. 2004;51(3):311-20.
14. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y. Criteria and recommendations for vitamin C intake. JAMA. 1999;281(15):1415-1453.
15. Magistretti NJ , Conti M, Cristini A. Antiulcer activity of an anthocyanidin from Vaccinium myrtillus. Arzneim-Forsch. 1988;38:686-690.
16. Marteau P, Boutron-Ruault MC. Nutritional advantages of probiotics and prebiotics. Br J Nutr. 2002;87(Suppl 2)):S153-S157.
17. Marteau PR. Probiotics in clinical conditions. Clin Rev Allergy Immunol. 2002;22(3):255-273.
18. Martin B. Prevention of gastrointestinal complications in the critically ill patient. AACN Adv Crit Care. 2007;18(2):158-66.
19. McManus TJ. Helicobacter pylori: an emerging infectious disease. Nurs Pract. 2000;25(8):42-46.
20. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion. 1999;60(3):203-209.
21. Olafsson S, Berstad A. Changes in food tolerance and lifestyle after eradication of Helicobacter pylori. Scand J Gastroenterol. 2003;38(3):268-76.
22. Pikalov AA, Kharin VV. Use of spinal manipulative therapy in the treatment of duodenal ulcer: a pilot study. J Manipulative Physiol Ther. 1994;17;310-313.
23. Qasim A, O'Morain CA. Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther. 2002;16(Suppl 1):24-30.
24. Ryan SW. Management of dyspepsia and peptic ulcer disease. Altern Ther Health Med. 2005;11(5):26-9; quiz 30.
25. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
26. Sugimoto N, Yoshida N, Nakamura Y, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Influence of vitamin E on gastric mucosal injury induced by Helicobacter pylori infection. Biofactors. 2006;28(1):9-19.
27. Vonkeman HE, Fernandes RW, van de Laar MA. Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers. Int J Clin Pharmacol Ther. 2007;45(5):281-8.
28. Woodward M, Tunstall-Pedo H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur J Gastroenterol Hepatol. 2001;13(3):233-237.
29. You WC, Zhang L, Gail MH, et al. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. Int J Epidemiol. 1998;27(6):941-944.